A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy

ConclusionWhile meeting its a priori feasibility criteria for patient engagement, the slow accrual means that conducting a large pragmatic trial would require overcoming the barriers to physician recruitment.TRIAL REGISTRATION: NCT02688998

http://link.springer.com/10.1007/s10549-019-05388-5

Source: Breast Cancer Research and Treatment - October 17, 2019 Category: Cancer & Oncology Source Type: research